|Venture Round, 3/2012 |
Florida Growth Fund
|Private Equity, 10/2013 ||$27M|
|Debt, 4/2011 ||$2M|
|Debt, 9/2011 ||$5M|
|Debt, 12/2011 ||$1.43M|
|Debt, 7/2012 |
Oxford Finance Corporation
|Debt, 10/2013 |
Florida Growth and Florida Opportunity Funds
LensAR, Inc. is a leader in the development and commercialization of a next generation laser and advanced 3D imaging technology for refractive cataract surgery.
Previous generations of the LensAR™ Laser System have been cleared by FDA for anterior capsulotomy and lens fragmentation. For other indications it is an investigational device limited by US law to investigational use only. The system has been used in more than 600 eyes outside the United States to date.